Blog
Pulmatrix (PULM) Q2 Revenue Falls 100%
Pulmatrix (NASDAQ:PULM), a biotechnology company known for its dry powder inhalation delivery platform iSPERSE™, released its second quarter results on August 6, 2025, covering the quarter that
F&g Annuities (FG) Q2 Revenue Up 16%
F&g Annuities & Life (NYSE:FG), a major provider of annuities and life insurance serving both retail and institutional clients, reported its financial results for the second quarter of fiscal 2025
Gladstone (GOOD) Q2 Revenue Rises 5%
Gladstone Commercial (NASDAQ:GOOD), a real estate investment trust (REIT) focused on single-tenant industrial and office properties, reported its second quarter 2025 results on August 6, 2025. The
TransAct (TACT) Q2 Revenue Jumps 19%
TransAct Technologies (NASDAQ:TACT), a technology supplier focused on printing and software equipment for the food service and gaming industries, released second-quarter 2025 earnings on August 6
Openlane (KAR) Q2 Revenue Jumps 9%
Openlane (NYSE:KAR), a leading digital marketplace operator for wholesale used vehicles, reported its second quarter 2025 earnings on August 6, 2025. The most notable news from the release was a
OppFi (OPFI) Q2 Revenue Jumps 13%
OppFi (NYSE:OPFI), a digital lending platform focused on serving consumers who are underserved by traditional financial institutions, reported its second-quarter 2025 financial results on August 6
Adma Biologics (ADMA) Q2 Revenue Up 14%
Adma Biologics (NASDAQ:ADMA), a plasma-derived biologics manufacturer focused on immunotherapies, released its earnings for Q2 2025 on August 6, 2025. The quarter showed continued revenue growth
Seres (MCRB) Q2 Loss Narrows 34%
Seres Therapeutics (NASDAQ:MCRB), a clinical-stage biotech focused on microbiome therapeutics, released its second quarter 2025 earnings on August 6, 2025. The main highlight was a narrowing net
Artiva (ARTV) Q2 Loss Widens 19.7%
Artiva Biotherapeutics (NASDAQ:ARTV), a clinical-stage biotechnology company pioneering allogeneic natural killer (NK) cell therapies for autoimmune diseases, released its financial results for the
Brookdale (BKD) Q2 Revenue Rises 4.6%
Brookdale Senior Living (NYSE:BKD), the nationwide operator of senior living communities, released its results for Q2 2025 on August 6, 2025. The period saw a notable jump in occupancy and stronger
Certara (CERT) Q2 Revenue Jumps 12%
Certara (NASDAQ:CERT), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue
Upstream Bio (UPB) Q2 R&D Soars 169%
Upstream Bio (NASDAQ:UPB), a biotechnology company developing new therapies for respiratory diseases, released its second quarter 2025 results on August 6, 2025. The main headline was rapid
CRH (CRH) Q2 Revenue Rises 6%
CRH (NYSE:CRH), the global building materials firm, reported its earnings release for the second quarter of fiscal 2025 on August 6, 2025. The company delivered GAAP revenue of $10.2 billion and
Boeing Defense Workers Just Went on Strike. Should Investors Be Concerned?
More than 3,200 Boeing (NYSE: BA) workers at the company's St. Louis-area defense factories went on strike Monday after the International Association of Machinists and Aerospace Workers (the IAM
Inspired (INSE) Q2 Revenue Jumps 7%
Inspired Entertainment (NASDAQ:INSE), a gaming technology provider covering casino systems, virtual sports, and interactive gaming content, released its results on August 6, 2025. The business
AnaptysBio (ANAB) Q2 Revenue Jumps 103%
AnaptysBio (NASDAQ:ANAB), a clinical-stage biotechnology company focused on innovative immunology therapeutics for autoimmune and inflammatory diseases, released its Q2 2025 earnings on August 6
Pyxus (PYYX) Q1 Revenue Falls 20%
Pyxus International (OTC:PYYX), a global leaf tobacco merchant and supply chain manager, released its first-quarter fiscal 2026 results on August 6, 2025. Revenue (GAAP) for Q1 FY2026 was $508.8
Paycom (PAYC) Q2 Revenue Rises 10.5%
Paycom (NYSE:PAYC), a leading provider of cloud-based human capital management (HCM) software, reported second quarter 2025 results on August 6, 2025. The company posted GAAP revenue of $483.6
Royalty Pharma (RPRX) Q2 Receipts Up 20%
Royalty Pharma Plc (NASDAQ:RPRX), a leader in acquiring royalties on biopharmaceutical products, released second quarter results on August 6, 2025. The most notable news: Royalty Receipts—its
Dayforce (DAY) Q2 EPS Jumps 27%
Dayforce (NYSE:DAY), a global provider of human capital management (HCM) software, released its second-quarter 2025 earnings on August 6, 2025. The company reported notable earnings and revenue
EverCommerce (EVCM) Q2 Revenue Up 5%
EverCommerce (NASDAQ:EVCM), a software firm specializing in digital solutions for service-based small and medium-sized businesses (SMBs), released its results for Q2 2025 on August 6, 2025. The
Procept (PRCT) Q2 Revenue Jumps 48%
Procept BioRobotics (NASDAQ:PRCT), a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia (BPH) treatment, posted second-quarter 2025 results on
Verra Mobility (VRRM) Q2 Revenue Up 6%
Verra Mobility (NASDAQ:VRRM), a leader in smart mobility technology serving commercial fleets and government agencies, released its second-quarter results on August 6, 2025. The headline news from
Zentalis (ZNTL) Q2 Loss Narrows 70%
Zentalis Pharmaceuticals (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company focused on developing cancer therapies, released its second quarter earnings on August 6, 2025. The headline news
Astec (ASTE) Q2 EPS Jumps 59%
Astec Industries (NASDAQ:ASTE), a leading manufacturer of equipment for road building and aggregate processing, reported results for Q2 2025 on August 6, 2025. In this report, the company delivered


